Global Adiponectin Testing Market: Snapshot
Adioponectin has shown substantial clinical potential as an adipocyte-derived protein in the pathophysiology of the metabolic diseases and coronary artery disease. Higher levels of circulating adiponectin is linked with high risk of adverse cardiovascular events, pre-diabetes, and metabolic syndrome. Several studies done on animal models have highlighted these findings, a key evolutionary factor for the adiponectin testing market. The health care industry has also focused form benefitting from the testing on animals where anti-inflammatory, antiatherogenic, cardiomyocyte-protective, and insulin-sensitizing properties of the hormone is utilized.
Over the recent decade, substantial efforts have been made in exploring the use of adiponectin testing as a potential biomarker in insulin sensitivity and obesity in human patients. Still, the test isn’t considered as a key determinant in conclusively identifying metabolic disease risks in patients. However, in recent years, the testing has growing in application for livestock.
The key application areas of the adiponectin testing are for diagnostics and research. Methods used comprise enzyme linked immunosorbent assay (ELISA) and enzyme immunoassay kits.
Need an overview of the report on Adiponectin Testing market? Ask for the brochure here
Global Adiponectin Testing Market: Growth Dynamics
The drive for the adiponectin testing market stems from the growing potential of adipose-derived products as a drug target to treat as well as prevent cardiometabolic diseases. New prospects have emerged in the market from growing body of research on understanding the pathophysiology of metabolic syndrome. The syndrome has evoked intense concern across worldwide healthcare systems. The marked mortality of diseases caused by this syndrome, such as non-alcoholic fatty liver disease (NAFLD), cardiovascular disease (CVD), and type 2 diabetes, has augmented the scope of the adiponectin testing market.
Drug makers in recent years have been focusing on new drug targets for insulin resistance (IR)-related metabolic disorders. This has also propelled industry interest in adiponectin testing. On the other hand, the growing demand for population for the diagnosis of hypoadiponectinemia has bolstered the prospects of the adiponectin testing market. Growing epidemic of obese population of all ages has also been fueling clinical studies on adiponectin levels in the body.
Looking for exclusive market insights from business experts? Request a Custom Report here
Global Adiponectin Testing Market: Notable Developments
The advent of functional food ingredients that claim to improve adipocyte health and adiponectin metabolism has expanded the avenue for market players. Over the years, studies that aims at the meta-analysis of the hormone as a biomarker for the detection of metabolic syndrome has gained steam, thereby boosting the adiponectin testing market. Advances in laboratory infrastructure for such tests have also propelled investments in the adiponectin testing market.
Manufacturers of testing kits in adiponectin testing market are striving to expand their product portfolio, and many have entered into new product launches and acquisitions. They have also garnered scientific backing based on meta-analysis of the clinical potential of adiponectin. Further, they have been gaining from epidemiology surveys with the objective of upholding the diagnostic potential of products in adiponectin testing market.
Some of the prominent players in the adiponectin testing market are:
- Thermo fisher Scientific Inc.
- Biorad laboratories
- Merck KGaA
- Boster Biological Technology
- Eagle Biosciences
Global Adiponectin Testing Market: Regional Assessment
The adiponectin market has been witnessing sizable avenues in the regions of North America, Europe, Latin America, Oceania, Asia, and the Middle East and Africa. Of these, North America has been contributing to the growth of the global market considerably. The growth can be apportioned to the growing potential of adipose-based products in reinforcing the drug pipelines for treating metabolic syndrome. Meanwhile, Asian countries with a burgeoning medical tourism has seen a promising potential.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.